CYCLAPEN-W (CYCLACILLIN) — FDA Approval NDA050509 (WYETH AYERST)
CYCLAPEN-W (CYCLACILLIN) — FDA Approval NDA050509 (WYETH AYERST) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CYCLAPEN-W; Active ingredients: CYCLACILLIN; Application number: NDA050509.
| Brand name | CYCLAPEN-W |
|---|---|
| Active ingredients | CYCLACILLIN |
| Application number | NDA050509 |
| Sponsor | WYETH AYERST |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19790913 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →